UK markets closed

INO Jun 2024 10.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.8500+0.4200 (+29.37%)
As of 09:52AM EDT. Market open.
Full screen
Previous close1.4300
Open1.4700
Bid1.3000
Ask3.0000
Strike10.00
Expiry date2024-06-21
Day's range1.4700 - 1.8500
Contract rangeN/A
Volume3
Open interest36
  • PR Newswire

    INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

    INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that INOVIO's President and CEO, Dr. Jacqueline Shea, and Chief Medical Officer, Dr. Michael Sumner will participate in a virtual fireside chat hosted by Sudan Loganathan, Ph.D., Managing Director and equity research analyst at Stephens, Inc.

  • PR Newswire

    INOVIO Reports Inducement Grants Under Inducement Plan

    INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an equity grant to a newly hired employee under its 2022 Inducement Plan (the "Inducement Plan").

  • GuruFocus.com

    Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

    Explore key financial outcomes and strategic updates from Inovio Pharmaceuticals Inc's first quarter of 2024, signaling robust progress and operational efficiency.